1,355 results on '"Jassem, Jacek"'
Search Results
2. Targeting BTLA with the peptide inhibitor HVEM(14-39) – A new way to restore the activity of T cells in melanoma
3. Quality indicators for evaluating cancer care in low-income and middle-income country settings: a multinational modified Delphi study
4. Efficacy of Lorlatinib in Treatment-Naive Patients With ALK-Positive Advanced NSCLC in Relation to EML4::ALK Variant Type and ALK With or Without TP53 Mutations
5. A View from the past into our collective future: the oncofertility consortium vision statement.
6. First-Line Nivolumab Plus Ipilimumab With Chemotherapy Versus Chemotherapy Alone for Metastatic NSCLC in CheckMate 9LA: 3-Year Clinical Update and Outcomes in Patients With Brain Metastases or Select Somatic Mutations
7. European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission
8. Real-world treatment outcomes in patients with HR+ HER2- advanced breast cancer treated with CDK4/6 inhibitors and endocrine therapy.
9. The effect of gD-derived peptides on T cell immune response mediated by BTLA-HVEM protein complex in melanoma patients
10. Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases
11. Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial
12. Pathway-level mutation analysis in primary high-grade serous ovarian cancer and matched brain metastases
13. Stroke heralding granulomatosis with polyangiitis
14. Neurotoxicity-sparing radiotherapy for brain metastases in breast cancer: a narrative review
15. Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1–Selected NSCLC
16. Deep Learning-based, multiclass approach to cancer classification on liquid biopsy data
17. Cell-free DNA methylation profile potential in the diagnosis of lung squamous cell carcinoma
18. The European Code of Cancer Practice
19. Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First‐Line Metastatic Colorectal Cancer
20. ALK alterations in salivary gland carcinomas
21. The effect of gD-derived peptides on T cell immune response mediated by BTLAHVEM protein complex in melanoma patients.
22. Infectious disease prophylaxis and treatment in cancer patients, with particular emphasis on COVID-19. Interdisciplinary position statement of Polish experts.
23. Can an Integrative SNP Approach Substitute Standard Identification in Comprehensive Case/Control Analyses?
24. Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I–III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort
25. 606 IMpower110: Tertiary lymphoid structures (TLS) and clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with first-line atezolizumab or chemotherapy
26. Radiotherapy-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with laryngeal cancer indicate poor prognosis
27. Heterogeneity in precision oncology
28. Transcriptomic landscape of blood platelets in healthy donors
29. Chronological Trends in Progression-Free, Overall, and Post-Progression Survival in First-Line Therapy for Advanced NSCLC
30. Fertility preservation during oncological treatment.
31. Author comment: Heterogeneity in precision oncology — R1/PR5
32. Fertility preservation during oncological treatment
33. Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project
34. Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform
35. Data from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
36. Supplementary Figure S1-S10 from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
37. Supplementary Table 1 from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
38. Supplementary Material and Methods from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
39. Cardiac exposure in left-sided breast cancer patients undergoing deep inspiratory breath hold radiation therapy
40. Platelet-Based Liquid Biopsies through the Lens of Machine Learning
41. Post-mastectomy radiation therapy after breast reconstruction: Indications, timing and results
42. Brain Metastasis Prediction by Transcriptomic Profiling in Triple-Negative Breast Cancer
43. PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer
44. Early biochemical and radiographic response after one cycle of [177Lu]Lu-PSMA I&T radioligand therapy in metastatic castration-resistant prostate cancer patients.
45. Supplementary Data from An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non–Small-Cell Lung Cancer
46. Data from Novel Functional Germline Variants in the VEGF Receptor 2 Gene and Their Effect on Gene Expression and Microvessel Density in Lung Cancer
47. Supplementary Tables 2 - 4 from FGFR1 mRNA and Protein Expression, not Gene Copy Number, Predict FGFR TKI Sensitivity across All Lung Cancer Histologies
48. Supplementary Figure Legends from Profound Prevention of Experimental Brain Metastases of Breast Cancer by Temozolomide in an MGMT-Dependent Manner
49. Supplementary Figure 1 from Profound Prevention of Experimental Brain Metastases of Breast Cancer by Temozolomide in an MGMT-Dependent Manner
50. Supplementary Table 5 from Novel Functional Germline Variants in the VEGF Receptor 2 Gene and Their Effect on Gene Expression and Microvessel Density in Lung Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.